Document is current
Any future updates will be listed below
-
Authors
Topriceanu, Constantin-Cristian
Dev, Eesha
Ahmad, Mahmood
Hughes, Rebecca
Shiwani, Hunain
Webber, Matthew
Direk, Kenan
Wong, Andrew
Ugander, Martin
Moon, James C.
Hughes, Alun D.
Maddock, Jane
Schlegel, Todd T.
Captur, Gabriella
-
Funding
Funding for this research was provided by:
BHF
Barts Charity HeartOME1000
Economic and Social Research Council
Horizon 2020 Framework Programme
NIHR UCL Hospitals Biomedical Research Centre
- License Information
-
More Information
Article History
Received: 27 June 2023
Accepted: 29 September 2023
First Online: 18 October 2023
Declarations
:
: The 2006–2010 NSHD data collection sweep included an in-depth cardiovascular assessment and was granted ethical approval from the Greater Manchester Local Research Ethics Committee and the Scotland Research Ethics Committee [], with written informed consent obtained from all study participants. Our project was approved by the NSHD committee. All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: The views expressed in this article are those of the authors. TTS is owner and founder of Nicollier-Schlegel SARL, which performs ECG interpretation consultancy using software that can quantify the advanced ECG measures used in the current study. TTS and MU are owners and founders of Advanced ECG Systems, a company that is developing commercial applications of advanced ECG technology used in the current study. JCM is the chief executive officer of Myocardium AI and has served on advisory boards for Genzyme and Sanofi. The remaining authors declare that they have no potential conflicts of interest.
